首页> 美国卫生研究院文献>other >Distinguishing between Unipolar Depression and Bipolar Depression: Current and Future Clinical and Neuroimaging Perspectives
【2h】

Distinguishing between Unipolar Depression and Bipolar Depression: Current and Future Clinical and Neuroimaging Perspectives

机译:区分单极性抑郁和双极抑郁症:当前和未来的临床和神经影像观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Differentiating bipolar disorder (BD) from recurrent unipolar depression (UD) is a major clinical challenge. Main reasons for this include the higher prevalence of depressive relative to hypo/manic symptoms during the course of BD illness and the high prevalence of subthreshold manic symptoms in both BD and UD depression. Identifying objective markers of BD might help improve accuracy in differentiating between BD and UD depression, to ultimately optimize clinical and functional outcome for all depressed individuals. Yet, only eight neuroimaging studies to date directly compared UD and BD depressed individuals. Findings from these studies suggest more widespread abnormalities in white matter connectivity and white matter hyperintensities in BD than UD depression, habenula volume reductions in BD but not UD depression, and differential patterns of functional abnormalities in emotion regulation and attentional control neural circuitry in the two depression types. These findings suggest different pathophysiologic processes, especially in emotion regulation, reward and attentional control neural circuitry in BD versus UD depression. This review thereby serves as a “call to action” to highlight the pressing need for more neuroimaging studies, using larger samples sizes, comparing BD and UD depressed individuals. These future studies should also include dimensional approaches, studies of at risk individuals, and more novel neuroimaging approaches, such as, connectivity analysis and machine learning. Ultimately, these approaches might provide biomarkers to identify individuals at future risk for BD versus UD, and biological targets for more personalized treatment and new treatment developments for BD and UD depression.
机译:区分双相情感障碍(BD)与复发性单相抑郁(UD)是一项重大的临床挑战。造成这种情况的主要原因包括在BD疾病过程中,抑郁症相对于低躁狂症状的患病率较高,而在BD和UD抑郁症中,阈下躁狂症状的患病率较高。鉴定BD的客观标志物可能有助于提高区分BD和UD抑郁症的准确性,从而最终优化所有抑郁症患者的临床和功能结局。然而,迄今为止只有八项神经影像学研究直接比较了UD和BD抑郁症患者。这些研究的发现表明,与UD抑郁症相比,BD的白质连通性和白质高强度异常分布更广泛,BD的ha管体积减少,但UD抑郁症没有减少,以及两种抑郁症的情绪调节和注意控制神经回路功能异常的差异模式类型。这些发现提示不同的病理生理过程,尤其是在BD与UD抑郁症的情绪调节,奖赏和注意力控制神经回路方面。因此,本综述是“呼吁采取行动”,以强调迫切需要进行更多的神经影像学研究,使用更大的样本量,比较BD和UD抑郁的个体。这些未来的研究还应包括维度方法,对高风险个体的研究以及更新颖的神经成像方法,例如连接性分析和机器学习。最终,这些方法可能会提供生物标记物,以识别将来可能患BD与UD的风险的个体,并为更个性化的治疗以及针对BD和UD抑郁症的新治疗方法提供生物学目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号